Clinical Trial Update: Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D [Phase 3]

View source ↗

Summary

Phase 3 trial update on the SonRtip lead with automatic AV-VV optimization in PARADYM RF SonR CRT-D for heart failure patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• PARADYM RF SonR CRT-D

Snippet

Sponsor: MicroPort CRM | Conditions: Heart Failure NYHA Class III and Ambulatory IV | Phase 3 | Status: UNKNOWN